Related Experiment Video
Updated: Jul 17, 2026

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome
Published on: May 22, 2019
An X chromosome gene, WTX, is commonly inactivated in Wilms tumor
Miguel N Rivera1, Woo Jae Kim, Julie Wells
1Massachusetts General Hospital Cancer Center, Harvard Medical Center, Boston, MA 02114, USA.
Abstract:
Wilms tumor is a pediatric kidney cancer associated with inactivation of the WT1 tumor-suppressor gene in 5 to 10% of cases. Using a high-resolution screen for DNA copy-number alterations in Wilms tumor, we identified somatic deletions targeting a previously uncharacterized gene on the X chromosome. This gene, which we call WTX, is inactivated in approximately one-third of Wilms tumors (15 of 51 tumors). Tumors with mutations in WTX lack WT1 mutations, and both genes share a restricted temporal and spatial expression pattern in normal renal precursors. In contrast to biallelic inactivation of autosomal tumor-suppressor genes, WTX is inactivated by a monoallelic "single-hit" event targeting the single X chromosome in tumors from males and the active X chromosome in tumors from females.
Insights
Researchers discovered a new gene, WTX, on the X chromosome that is inactivated in about one-third of Wilms tumors, a pediatric kidney cancer. This finding offers new insights into the genetic basis of this disease.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Wilms tumor is a common pediatric kidney cancer.
- WT1 tumor-suppressor gene inactivation occurs in 5-10% of Wilms tumors.
- The genetic landscape of Wilms tumor requires further elucidation.
Purpose of the Study:
- To identify novel genes involved in Wilms tumor development.
- To investigate the role of X-chromosome alterations in Wilms tumor pathogenesis.
- To characterize a newly identified gene, WTX, and its function.
Main Methods:
- High-resolution screening for DNA copy-number alterations in Wilms tumor samples.
- Somatic deletion analysis targeting X-chromosome genes.
- Mutation analysis of the identified WTX gene.
- Comparative analysis with WT1 gene mutations and expression patterns.
Main Results:
- A novel gene, WTX, on the X chromosome was identified.
- WTX is inactivated by somatic deletions in approximately one-third (15 of 51) of Wilms tumors.
- WTX inactivation was mutually exclusive with WT1 mutations.
- WTX and WT1 share similar restricted expression patterns in normal renal precursors.
- WTX inactivation occurs via a monoallelic "single-hit" event.
Conclusions:
- WTX is a novel tumor-suppressor gene implicated in Wilms tumorigenesis.
- WTX functions as a tumor suppressor, potentially cooperating with or acting in parallel to WT1.
- The monoallelic inactivation mechanism of WTX provides a new model for X-linked tumor suppressor genes.
Related Concept Videos
X-Inactivation
X-inactivation
Canonical Wnt Signaling Pathway
Inheritance of Chromatin Structures
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
